Key findings from the study:
1. Continuation Rate: The study reported an overall continuation rate of 93% after two insertions of hormone pellets, with women having a slightly higher continuation rate than men. This suggests that patients found the therapy effective and tolerable.
2. Complication Rate: The overall complication rate for the procedure was less than 1%. The most common complication reported was pellet extrusion, with a higher occurrence in men compared to women.
3. Benefits for Women: The study highlighted the importance of testosterone therapy for women, even though it’s often associated with men. It found that testosterone played a vital role in women’s health and could alleviate symptoms associated with hormone deficiencies, including improved libido and relief from menopausal symptoms like hot flashes.
4. Safety and Efficacy: The research indicated that subcutaneous hormone pellet therapy was a safe and effective method for hormone replacement therapy, with lower complication rates compared to other forms of hormone administration.
5. Long-Term Use: The study suggested that the convenience of pellet therapy, with infrequent insertions, contributed to high patient retention and the potential for long-term hormone optimization.
In conclusion, the study provided evidence supporting the safety and effectiveness of subcutaneous hormone pellet therapy, particularly in the treatment of hormone deficiencies in both men and women. It emphasized the importance of testosterone therapy for women’s health and suggested that this method could offer disease prevention opportunities in addition to symptom relief.